Chance (30 July 2023)
"Critical Shortage Of Cancer Treating Drugs Now At Crisis Point"


 
Hello John and Doves,
 
The U.S. is facing a critical shortage of cancer drugs.  Is this a planned part of Agenda 2030?  Or are manufacturers decreasing production?  Or is this due to a huge increase in turbo cancers, new cancers and cancers coming out of remission due to the Covid 19 "vaccine"?
 
THEY are going after cancer treatments and the 'environmental impact' of cancer care.
 
In this article published in The Lance in February 2021.  The authors wrote, "The health-care industry is a major emitter of greenhouse gases, representing 10% of total emissions in the USA...Although the carbon footprint of cancer care has not been qualified, the focus on chemotherapies and radiotherapies and the frequency of patient's hospital attendance make cancer care likely to be a significant contributer.
 
The authors bring up the "ethical concerns of climate and health justice."  They ask, "Can the considerable emissions associated with state-of-the-art cancer care and development of novel therapeutics that benefit small numbers of patients be justified, when those most affected by the climate breakdown might be unable to access routine cancer prevention and care?"
 
The authors as "health-care professionals and advocates..for our communities" write that they have a responsibility to "ensure these changes are brought about as quickly as possible." They looked at the high cost of cancer treatment as it relates to 'the carbon foot print"- 'on-site energy expenditures, pharmaceutical production, ineffective medical devices, food delivery and waste, transportation and supply chain green house gas emissions."  
Cancer and climate change: the environmental impact of cancer care - The Lancet Oncology
 
And in this Lancet article published June 15, 2023 "Ongoing shortages of chemotherapy drugs in the USA - now among the worst in three decades - have reached crisis point, with as many as 100,000 patients affected."
Cancer care critically affected by USA drug shortages - The Lancet Oncology
 
And this article published in The Hill states, "From transporting patients to specialized treatment facilities to treating them in hospitals, cancer care requires a considerable amount of energy.  The hospital and pharmaceutical industry are the largest contributors to the U.S. health care system's carbon footprint..."  A study "found that the pharmaceutical industry is 50 percent more carbon-intensive than the automotive industry."
The carbon footprint of cancer care – The Hill
 
And in this article dated May 11, 2023 we find that "the US faces a near-record number of drug shortages, cancer treatments are among the hardest hit.  There is an active shortage of about two dozen chemotherapy drugs, the fifth most of any drug category..."The fact that we have this many chemo drugs in shortgage is really concerning," said Michael Ganio, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists."  There are "often not alternatives for chemotherapy drugs  And the shortages are affecting treatment for a broad range of cancers."
 
"Overall, the data from the University of Utah shows that there were more than 300 drugs with an active shortage in the US at the end of March, including nearly 50 new shortages that accumulated in the first three months of the year.  The last time active drug shortages - including both newly reported and ongoing - were this high was in 2014, the data shows."  "Shortages are still happening and they're not resolving, or they're not resolving as quickly as new shortages are starting, Ganio said."  The U.S. House of Representatives and Commerce Subcommittee on Oversight and Investigations "held a hearing exploring the root causes of these shortages."
 
"Increased demand is part of it."  "Hundreds of impending shortages loom..."  "There is severe patient impact happening every day......9 out of 10 oncologists say that drug shortages have led to patient harm, including death..."
Cancer drugs among top 5 most affected by shortages in the US | CNN
 
Is this "mysterious shortage of cancer treatment drugs a result of the push against this carbon foot print - in the push for Agenda 2030 goals?
 
"According to the American Cancer Society (ACS) ...treating patients for cancer is contributing to "climate change" because the so-called "carbon footprint" of the procedures is too large."
 
"Now in 2023, either predictively or by design, there is a mysterious lack of the usual drug-based tools that cancer clinicians use to treat patients.  Is all of this just one big strange coincidence, or was the plan all along to blame modern medicine for planetary warming while simultaneously phasing out cancer care under the guise of there no long being enough cancer drugs available to treat everyone?"
American Cancer Society: 'Carbon Footprint' of Treating Patients Is Too Big - Slay News
 
Those who have been following the adverse side effects of the Covid-19 vaccine realize that pharmaceuticals have been in high demand over the last two and a half years - needed to help many of these people now with heart conditions, auto immune diseases, blood clots and strokes, heart attacks, etc.  Drugs treating these conditions are in very high demand now.  And with the turbo cancers being reported - with people relapsing from previous 'stable' or 'in remission' cancers - we can see how cancer drug use is off the charts!
 
And we get many of these drugs from China.  Which doesn't help the pharmaceutical situation in the U.S.
 
Is it the "climate agenda" that's pushing this supply shortage?  Or the increase in demand due to the high number of Covid-19 "vaccine" injured?  Or both?  Or manufacturers aren't making as much?  Or a combination of reasons?
 
This is not good.  Often there is another drug that can be used to treat a condition - but cancer therapy is pretty drug specific.
 
"The shortage is now at the level that experts are calling the situation a "crisis point".  ...Corporate media outlets like Politico and PBS News are warning that both doctors and patients are increasingly having to make tough choices about what to do as an alternative.  Hospitals and cancer centers across the country are running out of two major injectable cancer drugs:  carboplatin and cisplatin."
American Cancer Society: 'Carbon Footprint' of Treating Patients Is Too Big - Slay News
 
This June 18, 2023 article has a video about these two cancer drugs:   PBS News reports that 93% of the centers are currently experiencing a shortage of carboplatin and 70% have a similar lack of displatin."  'Shortages place providers in a moral dilemma prioritizing drug use for patients who are curable vs those who are not.'  Patients worry about if they'll get their next treatment and if switching to another drug will shorten their lives.  Breast cancer, gynecological cancers, lung cancers, GI cancer, testicular cancers - very many are treated with these two prime cancer drugs.
Critical cancer drug shortage forces doctors, patients to make tough choices | PBS News Weekend
 
Something is very very wrong.  And it looks like 'hair on fire' is a bit too late - as nothing was done when they saw these shortages coming.  And it's not just chemo drugs.  Prayers for the people facing the chemo drug shortage.  We really need the cures, not the drugs..
 
Just be aware of drug shortages going on now.
 
Maranatha!
 
Chance